May 17, 2012
AUSTIN, Texas, May 17 — The childhood cancer research computing cluster created and donated by Dell for the Translational Genomics Research Institute (TGen) is ready to support the world's first precision medicine clinical trial for pediatric cancer. The computation performance of the cluster is expected to accelerate analysis and identification of targeted treatments beyond initial projections.
Oncologists from the Neuroblastoma and Medulloblastoma Translational Research Consortium (NMTRC) and biomedical researchers from TGen will use the new high performance computing and collaboration cloud to identify targeted treatments for pediatric cancer patients based on the specific genetic vulnerabilities of each child's tumor — an approach that could be used to treat many pediatric and adult cancers in the future.
Dell's team has completed the high performance computing cluster that will serve as the cloud's computational foundation and basis for a private cloud. When equipped with Dell's latest server technology—the PowerEdge M420—and a parallel approach to computation, TGen can analyze comprehensively a patient's tumor RNA profile in one day versus the seven days that were previously required—an important advantage in the battle against aggressive childhood cancers. With the dedicated computing cluster in place, Dell will begin to connect the biomedical researchers sequencing and analyzing patient tumors at TGen in Arizona with oncologists providing treatment to patients participating in the trial at 11 medical centers. The new cloud will eliminate the need to express mail hard drives containing tumor and diagnostic images and genomic sequencing data between locations.
There has been only one new treatment for pediatric cancer approved by the FDA since the 1980s, compared with 50 treatments approved for adult cancer in this same timeframe. As a result, pediatric oncologists have relied upon treatments designed for adults, with toxic side effects that are frequently as physically detrimental to the child as the cancer itself. Precision medicine can overcome these barriers with treatments that target the specific vulnerabilities of each child's tumor, leaving healthy cells untouched.
In related news, the NMTRC welcomed Dell Children's Medical Center in Austin, Texas, to its membership and the list of hospitals participating in the clinical trial as it continues to expand medical center participation in the US and globally. And Ronald McDonald House Charities announced Dell's contribution of $100,000 to support Ronald McDonald houses in 14 cities and the families who rely upon them when they are away from home for treatment.
Dell's donations of cloud computing to TGen for the precision medicine clinical trial and funds to Ronald McDonald House Charities are part of the company's multiyear, multimillion dollar commitment of technology, funding and employee engagement to improve childhood cancer treatment globally.
"There is no time to waste for children and families battling aggressive and deadly cancers like neuroblastoma," said James Coffin, Ph.D., vice president and general manager, Dell Healthcare and Life Sciences. "That's why Dell is focused on driving results faster—faster than our initial projections — for TGen and NMTRC so that they accelerate time-to-targeted treatment for children participating in the clinical trial and can open participation to more children over time."
"This conference provides a great opportunity for researchers, clinicians and families to assess the state of pediatric cancer care today," said Dr. Jeffrey Trent, TGen's President and Research Director. "The collaborative model behind this conference is a great example of how through partnerships we can positively move research and treatment forward at a pace not seen before."
"On behalf of the NMTRC, we are incredibly thankful for Dell's support and expertise to help in the care of our patients," said Giselle Sholler, Co-Director of the Pediatric Oncology Translational Research Program at the Van Andel Institute. "This meeting will bring together the top physicians, researchers and parent advocates working collaboratively to accelerate the search for a cure."
Dell Inc. (NASDAQ: DELL) listens to customers and delivers innovative technology and services that give them the power to do more. Dell's Powering the Possible program is funded by the company's pledge to contribute 1 percent of its pre-tax profits to learning, pediatric cancer, innovative social entrepreneurship and disaster relief initiatives that address unmet needs globally and enable human potential. Information about Dell Powering the Possible is available at www.dell.com/pediactriccancer.
As the leading provider of healthcare IT services in the world, Dell helps healthcare organizations harness the power of information to simplify administration; coordinate and manage patient care; transition from episodic care to prevention and wellness management and ultimately to deliver personalized medicine.
The Translational Genomics Research Institute (TGen) is a Phoenix, Arizona-based non-profit organization dedicated to conducting groundbreaking research for life changing results. Research at TGen is focused on helping patients with diseases such as cancer, neurological disorders and diabetes. TGen is on the cutting edge of translational research where investigators are able to unravel the genetic components of common and complex diseases. Working with collaborators in the scientific and medical communities, TGen believes it can make a substantial contribution to the efficiency and effectiveness of the translational process. TGen is affiliated with the Van Andel Research Institute in Grand Rapids, Michigan. For more information, visit: www.tgen.org.
About the Neuroblastoma and Medulloblastoma Translational Research Consortium
Founded in 2008, the NMTRC is a nationwide network of childhood cancer trials based at the Van Andel Research Institute and chaired by Dr. Giselle Sholler. The consortium includes the following clinical partners: Cardinal Glennon Children's Medical Center, Saint Louis University School of Medicine; Center for Children's Cancer and Blood Disorders at Arnold Palmer Hospital for Children, MD Anderson Cancer Center Orlando; Children's Mercy Hospitals and Clinics; Connecticut Children's Medical Center; Doernbecher Children's Hospital, Oregon Health & Science University; Helen DeVos Children's Hospital; Levine Children's Hospital; Medical University of South Carolina; National Cancer Institute; Rady Children's Hospital San Diego, UCSD School of Medicine and the University of Hawaii Cancer Center.
Researchers from the Suddhananda Engineering and Research Centre in Bhubaneswar, India developed a job scheduling system, which they call Service Level Agreement (SLA) scheduling, that is meant to achieve acceptable methods of resource provisioning similar to that of potential in-house systems. They combined that with an on-demand resource provisioner to ensure utilization optimization of virtual machines.
Experimental scientific HPC applications are continually being moved to the cloud, as covered here in several capacities over the last couple of weeks. Included in that rundown, Co-founder and CEO of CloudSigma Robert Jenkins penned an article for HPC in the Cloud where he discussed the emergence of cloud technologies to supplement research capabilities of big scientific initiatives like CERN and ESA (the European Space Agency)...
When considering moving excess or experimental HPC applications to a cloud environment, there will always be obstacles. Were that not the case, the cost effectiveness of cloud-based HPC would rule the high performance landscape. Jonathan Stewart Ward and Adam Barker of the University of St. Andrews produced an intriguing report on the state of cloud computing, paying a significant amount of attention to the problems facing cloud computing.
Jun 19, 2013 |
Ruan Pethiyagoda, Cameron Boehmer, John S. Dvorak, and Tim Sze, trained at San Francisco’s Hack Reactor, an institute designed for intense fast paced learning of programming, put together a program based on the N-Queens algorithm designed by the University of Cambridge’s Martin Richards, and modified it to run in parallel across multiple machines.
Jun 17, 2013 |
With that in mind, Datapipe hopes to establish themselves as a green-savvy HPC cloud provider with their recently announced Stratosphere platform. Datapipe markets Stratosphere as a green HPC cloud service and in doing so partnering with Verne Global and their Icelandic datacenter, which is known for its propensity in green computing.
Jun 12, 2013 |
Cloud computing is gaining ground in utilization by mid-sized institutions who are looking to expand their experimental high performance computing resources. As such, IBM released what they call Redbooks, in part to assist institutions’ movement of high performance computing applications to the cloud.
Jun 06, 2013 |
The San Diego Supercomputer Center launched a public cloud system for universities in the area designed specifically to run on commodity hardware with high performance solid-state drives. The center, which currently holds 5.5 PB of raw storage, is open to educational and research users in the University of California.
05/10/2013 | Cleversafe, Cray, DDN, NetApp, & Panasas | From Wall Street to Hollywood, drug discovery to homeland security, companies and organizations of all sizes and stripes are coming face to face with the challenges – and opportunities – afforded by Big Data. Before anyone can utilize these extraordinary data repositories, however, they must first harness and manage their data stores, and do so utilizing technologies that underscore affordability, security, and scalability.
04/02/2012 | AMD | Developers today are just beginning to explore the potential of heterogeneous computing, but the potential for this new paradigm is huge. This brief article reviews how the technology might impact a range of application development areas, including client experiences and cloud-based data management. As platforms like OpenCL continue to evolve, the benefits of heterogeneous computing will become even more accessible. Use this quick article to jump-start your own thinking on heterogeneous computing.